NUWELLIS, INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
NUWELLIS, INC. (NUWE) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $0 as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2019-11-08
- 2019-09-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $0.00.
- 2019-06-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $0.00.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |